Related Experiment Video

Updated: Jan 8, 2026

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

16.9K

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond

Linda Sundler Björkman1,2,3,4, Harish Eswaran1,2,5, Steven P Grover1,2,6,7

  • 1UNC Blood Research Center (L.S.B., H.E., S.P.G.), The University of North Carolina at Chapel Hill.

Arteriosclerosis, Thrombosis, and Vascular Biology
|December 18, 2025
PubMed

Insights

C1-inhibitor (C1INH) regulates key systems and shows therapeutic potential beyond hereditary angioedema. This review explores C1INH

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • C1-inhibitor (C1INH) is a crucial serine protease inhibitor regulating complement, coagulation, and kallikrein-kinin systems.
  • C1INH deficiency causes hereditary angioedema, for which C1INH products are established treatments.

Purpose of the Study:

  • To review the biological activities of C1INH.
  • To explore the pathophysiological roles of C1INH targets in various diseases.
  • To highlight the therapeutic potential of exogenous C1INH in diverse clinical settings.

Main Methods:

  • Literature review of C1INH biological activities.
  • Analysis of pathophysiological roles of C1INH targets.
  • Evaluation of therapeutic applications of C1INH in different conditions.

Main Results:

  • C1INH possesses multifunctional regulatory roles in critical physiological systems.
  • Evidence suggests C1INH's utility extends beyond hereditary angioedema.
  • Potential therapeutic applications identified in thromboembolism, ischemia-reperfusion injury, sepsis, transplantation, and COVID-19.

Conclusions:

  • C1INH is a versatile regulator with broad therapeutic potential.
  • Exogenous C1INH may offer new treatment strategies for various inflammatory and thrombotic conditions.
  • Further research into C1INH's applications is warranted for conditions like COVID-19 and sepsis.

Keywords:
angioedemas, hereditaryblood coagulationcomplement C1 inhibitor proteinthrombosisvascular diseases

More Related Videos

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

9.2K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.2K

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203